86238081
Apr 1, 2014
Feb 17, 2015
Medicines for human purposes, for the treatment of injury of optic nerve; Medicines for human purposes, for the treatment of functional constipation and for treatment of intestinal conditions; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; Medicines, namely, acetylsalicylic acid tablets for treatment of antithrombosis and for the treatment of unstable angina; Medicines for human purposes, for the treatment of pruritus and alopecia; Medicines for human purposes, for weight loss; Medicines for human purposes, for treatment of hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the treatment of pain of muscle cramp caused by inflammation and injury; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and chronic gastritis; Medicines for human purposes, for the treatment of infectious disease; Pharmaceutical preparations for the treatment of autoimmune disorders; Medicines for treating constipation
Pharmaceuticals